Literature DB >> 9073027

Granulomatous myositis: pathologic re-evaluation by immunohistochemical analysis of infiltrating mononuclear cells.

T Takanashi1, Y Suzuki, Y Yoshino, I Nonaka.   

Abstract

To characterize the non-caseating granuloma formation in granulomatous myositis, we analyzed infiltrating mononuclear cells in 7 patients including 2 sarcoid patients, using monoclonal antibodies with a modified immunoperoxidase method. All granulomas consisting of epithelioid, infiltrating mononuclear cells and multinucleated giant cells had markedly increased numbers of CD45Ro-positive cells. The infiltrating inflammatory cells were mostly T lymphocytes and macrophages. The majority of T lymphocytes behaved as T helper/inducer subtype, expressing CD4 positivity. Although the ratio of CD4- to CD8-positive cells in the granuloma in muscle biopsies was not significantly different from that in other organs seen in systemic sarcoidosis, T helper/inducer and T suppressor/cytotoxic cells showed some characteristic distributions: CD4-positive cells accumulated in the center of, and CD8-positive cells at the periphery of, the granuloma. The distribution of infiltrating cells did not differ between muscle biopsies from patients with and without systemic sarcoidosis, suggesting that both groups share the same pathogenetic mechanism in granuloma formation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9073027     DOI: 10.1016/s0022-510x(96)00237-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Immune myopathy with large histiocyte-related myofiber necrosis.

Authors:  Alan Pestronk; Namita Sinha; Ziad Alhumayyd; Cindy Ly; Robert Schmidt; Robert Bucelli
Journal:  Neurology       Date:  2019-03-20       Impact factor: 9.910

2.  Plasmacytoid dendritic cells in cutaneous sarcoidosis.

Authors:  Ali Halawi; Mazen Kurban; Ossama Abbas
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  [Diagnosis and differential diagnosis of granulomatous myositis].

Authors:  H-J Gdynia; H Mogel; P Kühnlein; J Dorst; N Osterfeld; C A von Arnim; A-D Sperfeld
Journal:  Nervenarzt       Date:  2008-04       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.